EU long-term competitiveness strategy has to apply to the EU Pharma legislation

We would like to call on the Commission to stand by its commitment to the Long-term competitiveness of the EU and deliver a comprehensive competitiveness...

New European legislation designed to protect patients is delaying clinical trials for thousands of people...

The number of clinical trials delayed is expected to run into the hundreds, affecting up to 42,200 patients over the next three years, according to a survey...

EBC & EFPIA launch RETHINKING Alzheimer’s disease White Paper

On the occasion of the Brain Awareness Week, the European Brain Council (EBC) and EFPIA launched the RETHINKING Alzheimer’s disease White Paper, calling...

EU long-term competitiveness strategy has to apply to the EU Pharma legislation

We would like to call on the Commission to stand by its commitment to the Long-term competitiveness of the EU and deliver a comprehensive competitiveness...

New European legislation designed to protect patients is delaying clinical trials for thousands of people...

The number of clinical trials delayed is expected to run into the hundreds, affecting up to 42,200 patients over the next three years, according to a survey...

EBC & EFPIA launch RETHINKING Alzheimer’s disease White Paper

On the occasion of the Brain Awareness Week, the European Brain Council (EBC) and EFPIA launched the RETHINKING Alzheimer’s disease White Paper, calling...

Because we can’t afford not to - Let’s make a joint health check for cardiovascular disease (CVD) and...

Join us in the European Parliament

“Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation”, The Lancet,...

EFPIA reaction to leak of the proposed pharmaceutical legislation

Whether it is naivety, blind optimism or a more conscious decision for Europe to rely on innovation from the US and Asia, there should be no doubt that...

Industry Statement on the earthquakes in Turkey and Syria

Industry will continue to work with partners and authorities across Europe to provide further support where possible.

EFPIA response to EU Commission proposal for revised EMA Fees regulation

EFPIA welcomes the opportunity to provide feedback on the EU Commission proposal for a revised EMA Fees regulation.

EFPIA update on the readiness for mandatory use of the Clinical Trials Regulation

A majority of EFPIA members have already submitted at least one clinical trial application through the Clinical Trials Information System (CTIS), the electronic...

EBC & EFPIA hold RETHINKING Alzheimer’s event ahead of policy paper launch

The European Brain Council (EBC), in collaboration with EFPIA, organised a digital event looking at the need to rethink the way we approach detection and...

Europe’s cancer community sets out best practice guide to sustainable, equitable and transformative patient...

Smart investments in cancer care are urgently needed to alleviate demands on healthcare systems and improve access to cancer care

EFPIA response to medicines shortages reports

EFPIA member companies are not reporting shortages as a result of the situation in China, and where necessary have increased supply